+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Menopausal Hot Flashes Market 2021-2025

  • PDF Icon

    Report

  • 120 Pages
  • October 2021
  • Region: Global
  • TechNavio
  • ID: 5509397
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

This publisher has monitored the menopausal hot flashes market and according to this report it is poised to grow by $2.19 Billion during 2021-2025, progressing at a CAGR of 3.82% during the forecast period. The report the menopausal hot flashes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by changes in lifestyle and rise in disposable income.

The menopausal hot flashes market analysis includes the distribution channel segment and geographic landscape.

The menopausal hot flashes market is segmented as below:


By Distribution Channel


  • Offline
  • Online

By Geographical Landscape


  • North America
  • Europe
  • Asia

This study identifies the increase of women in the workforce as one of the prime reasons driving the menopausal hot flashes market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The report menopausal hot flashes market covers the following areas:


  • Menopausal hot flashes market sizing
  • Menopausal hot flashes market forecast

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading menopausal hot flashes market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc. Also, the menopausal hot flashes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

Executive Summary
  • Market Overview

Market Landscape
  • Market ecosystem
  • Value chain analysis

Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
  • Market Segmentation by Distribution channel
  • Market segments
  • Comparison by Distribution channel
  • Offline - Market size and forecast 2020-2025
  • Online - Market size and forecast 2020-2025
  • Market opportunity by Distribution channel

Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape
  • Overview

Vendor Landscape
  • Landscape disruption

Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.

Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)

Five Forces Analysis
2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Distribution channel - Market share 2020-2025 (%)
  • Comparison by Distribution channel
  • Offline - Market size and forecast 2020-2025 ($ million)
  • Offline - Year-over-year growth 2020-2025 (%)
  • Online - Market size and forecast 2020-2025 ($ million)
  • Online - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Distribution channel

Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges

Vendor Landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product and service
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product and service
  • AstraZeneca Plc - Key offerings
  • AstraZeneca Plc - Key customers
  • AstraZeneca Plc - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • Mylan NV - Overview
  • Mylan NV - Business segments
  • Mylan NV - Key offerings
  • Mylan NV - Key customers
  • Mylan NV - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Novo Nordisk AS - Overview
  • Novo Nordisk AS - Business segments
  • Novo Nordisk AS - Key offerings
  • Novo Nordisk AS - Key customers
  • Novo Nordisk AS - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations

Executive Summary

The publisher has identified the following companies as the key players in the global menopausal hot flashes market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, GlaxoSmithKline Plc, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, and Pfizer Inc.

Commenting on the report, an analyst from the publisher said 'The latest trend gaining momentum in the market is increase of women in the workforce.'

According to the report, one of the major drivers for this market is the change in lifestyle.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.